FemTech Untapped is an online program and a global movement tapping into areas of women’s health that have long been underserved, underresearched, and underfunded. In 2022, they will be covering a wide range of topics with a goal to educate and destigmatize areas of FemTech that still remain “untapped”.
Join every month for a series of events where they will cover topics from diversity and inclusion in the femtech space, to menstrual health and sextech, to mental and cardiovascular health for women and underrepresented audiences and groups in the healthcare space. Together, teams can all work towards FemTech being more accessible and inclusive.
About this event – How technology can help end suffering in silence: Endometriosis, PCOS, and gynaecological cancers
Endometriosis affects roughly 10% (190 million) of reproductive age women and girls globally. It takes on average seven years to diagnose it and in the meantime, women are often dismissed, misdiagnosed, and misunderstood.
There are five gynaecological cancers (Ovarian, Cervical, Uterine (womb), Vaginal and Vulval), but they are rarely discussed in the public. Gynaecological cancers have a devastating mortality rate of 37%, according to Lady Garden Foundation, and understanding the symptoms and early detection can save lives. That’s why more open conversation and education is needed.
WHO reports that there are over 116 million women around the world who are affected by PCOS, the most common hormonal disorder. Yet, although so many women are going through this, they often feel lonely, neglected, and are left to suffer in silence for years.
The time has come to put these topics on the public agenda, to give women the information and education they need, and the healthcare they deserve. Join the team to find out how technology can help end suffering in silence from the founders and innovators who are pushing the frontiers of innovation and working on the solutions for female health issues that were neglected and under-researched for way too long. Speakers include: